GILD,Gilead Sciences, Inc. | Healthcare

Healthcare

GILD

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Gilead Sciences, Inc.GILD

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis.

It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections.

Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc., and Tentarix Biotherapeutics Inc., as well as a partnership with Assembly Biosciences, Inc. to develop next-generation therapeutics for serious viral diseases.

The company was incorporated in 1987 and is headquartered in Foster City, California.

Latest News >

Omicron cases doubling in 1.5 to 3 days in areas with local spread: WHO

Dec 18, 2021

Omicron is spreading rapidly in countries with high levels of population immunity, but it is unclear if this is due to the virus' ability to evade immunity, its inherent increased transmissibility or a combination of both, the WHO said.

Bharat Biotech, Dunc Minh donate 2 lakh Covaxin doses to Vietnam

Dec 18, 2021

The Republic of Vietnam will receive two lakh doses of Bharat Biotech's COVID-19 vaccine, Suchitra Ella, Joint Managing Director of Bharat Biotech, said at a function hosted by Vuong Dinh Hue, President of the National Assembly of the Socialist Republic of Vietnam in the national capital. Covaxin has received Emergency Use Listing (EUL) in Vietnam.

Explained: Parvovirus that infected 2,000 dogs in Maharashtra’s Amravati

Dec 18, 2021

The parvovirus is a highly contagious viral disease that dogs can get. It has a 90 percent mortality rate, but an be prevented with proper vaccination, experts have said.

Ready to enhance troop deployment in Eastern Ladakh if need be: IAF chief

Dec 18, 2021

The Indian Air Force is continuing deployment in Eastern Ladakh as the standoff with China persists and the Force is ready to enhance the presence of troops if the need arises, IAF Chief Air Chief Marshal Vivek Ram Chaudhari has said. He said that despite some disengagement in certain areas in Eastern Ladakh, complete disengagement has not taken place. "We are deployed, we are prepared to take on any challenge that may face us in that area with the shortest of notice," he said.